Back to Search
LAURA CHAPLIN, DO
DO
Family Medicine Physician
NPI: 1093337909IndividualAccepts Medicare
Specialties, Licenses & Credentials
CMS Specialties
PrimaryFAMILY PRACTICE
Education
OTHER
Class of 2020
Research & Publications (7)
HEXIM1 regulates 17beta-estradiol/estrogen receptor-alpha-mediated expression of cyclin D1 in mammary cells via modulation of P-TEFb.
PMID 18757415·Cancer Res·2008
7-preclinical
hPMC2 is required for recruiting an ERbeta coactivator complex to mediate transcriptional upregulation of NQO1 and protection against oxidative DNA damage by tamoxifen.
PMID 18663360·Oncogene·2008
8-other
Mutation of the HEXIM1 gene results in defects during heart and vascular development partly through downregulation of vascular endothelial growth factor.
PMID 18079413·Circ Res·2008
7-preclinical
Protective roles of quinone reductase and tamoxifen against estrogen-induced mammary tumorigenesis.
PMID 17160017·Oncogene·2007
7-preclinical
Estrogen receptor regulation of quinone reductase in breast cancer: implications for estrogen-induced breast tumor growth and therapeutic uses of tamoxifen.
PMID 15769636·Front Biosci·2005
6-review
Differential induction of quinone reductase by phytoestrogens and protection against oestrogen-induced DNA damage.
PMID 15456407·Biochem J·2005
8-other
Tumour targeting of humanised cross-linked divalent-Fab' antibody fragments: a clinical phase I/II study.
PMID 11986771·Br J Cancer·2002
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 67 S Bedford St
Burlington, MA 01805 - Phone
- (781) 744-8000
Quick Facts
- NPI
- 1093337909
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 2
- Years in Practice
- 6
- Publications
- 7
Are you this provider?
Claim Your Profile